T1	Participants 658 756	One third of the patients of the international trial were treated at LinkÃ¶ping University Hospital
T2	Participants 901 912	27 patients
T3	Participants 998 1008	9 patients
T4	Participants 1117 1127	9 patients
T5	Participants 1215 1225	9 patients
